Q Fever News and Research

RSS

Remdesivir likely to be highly effective treatment for COVID-19

The drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists.

14 Dec 2020

Researchers test commercial assays to detect SARS-CoV-2 antibodies six months after infection

Researchers at the Hospices Civils de Lyon (HCL) in France found that people infected with SARS-CoV-2 can develop antibodies that persist for up to six months. After testing commercial assays to detect antibodies, the Wantai antibody assay has a positivity rate of 100%.

14 Dec 2020

Wastewater testing can detect COVID-19 cases weeks before people show clinical signs

A new study from Australia’s national science agency, CSIRO, and the University of Queensland provides further evidence that wastewater (untreated sewage) testing can detect COVID-19 in communities weeks before people display symptoms, suggesting this testing could provide a targeted early detection system as economies re-open and people become more mobile.

14 Dec 2020

Case study suggests kindergartens are not SARS-CoV-2 super-spreaders

A new study by researchers at the Institute of Tropical Medicine and International Health at the Charite Universitaetsmedizin Berlin found that kindergartens are not silent transmission reservoirs.

11 Dec 2020

New analysis method could pave the way for important breakthroughs in immunotherapy

In a new study, researchers at Uppsala University have been able to show differences in how Rituximab, a monoclonal antibody drug, interacts with the blood of healthy individuals compared to patients with chronic lymphatic leukemia. This has awakened hopes that this analysis method could pave the way for important breakthroughs in immunotherapy research and treatment.

11 Dec 2020

Favipiravir does not attenuate the progression of COVID-19

Scientists have conducted an observational study to evaluate the efficacy of an anti-influenza medicine favipiravir in treating hospitalized COVID-19 patients.

11 Dec 2020

Severe cortical damage associated with COVID-19 case report

In December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began to cause a flu-like infection in people living in Wuhan, China.

10 Dec 2020

Takeda brings innovative pipeline portfolio to patients for sustained revenue growth

As part of its Wave 1 Pipeline Market Opportunity Call, Takeda Pharmaceutical Company Limited provided an update on its pipeline portfolio, which has the potential to contribute significantly to revenue growth for the company over the next decade.

From Takeda 10 Dec 2020

Study: TMEM41B transmembrane protein is a critical factor for SARS-CoV-2 replication

A single protein that appears necessary for the COVID-19 virus to reproduce and spread to other cells is a potential weakness that could be targeted by future therapies.

10 Dec 2020

Interim analysis of phase 3 study shows excellent efficacy of SARS-CoV-2 vaccine

South African study data were used to evaluate the safety of the vaccine in the results just published, but not its efficacy [which refers to the percentage reduction of disease].

9 Dec 2020

Change in mental status or falls may be misinterpreted as infection in nursing homes

There is a widespread belief that a change in the mental status or an increase in falls in a nursing home resident may indicate an underlying infection.

9 Dec 2020

Virginia Tech researchers awarded NIH grant to develop Zika virus vaccine

Flaviviruses -- a group of viruses transmitted by ticks or mosquitoes -- infect an estimated 400 million people annually with diseases like yellow fever, Dengue fever, West Nile virus, and, most recently, Zika virus.

9 Dec 2020

The impact of COVID-19 on emergency medical services: a case study

A team of researchers based in Turkey has now studied the pandemic's effect on emergency medical services (EMS). Their study, titled "Effects of COVID‐19 pandemic on emergency medical services," was published in the latest issue of The International Journal of Clinical Practice.

9 Dec 2020

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

First full results from interim analysis confirm that the Oxford COVID-19 vaccine (AZD1222) has an acceptable safety profile and is efficacious against symptomatic COVID-19 disease, with no hospitalizations or severe disease reported in the COVID-19 vaccine group so far.

9 Dec 2020

COVID-19 has been reported to trigger Guillain–Barré syndrome

Researchers at Rutgers Robert Wood Johnson Medical School have reported the first instance of COVID-19 triggering a recurrence of Guillain-Barré Syndrome - a rare disorder where the body's immune system attacks nerves and can lead to respiratory failure and death.

8 Dec 2020

COVID-19 may be linked to acute appendicitis in children

Researchers at the University of Virginia have recently presented a case series pointing to a potential association between infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the development of acute appendicitis in children.

8 Dec 2020

Q Fever News and Research

Remdesivir likely to be highly effective treatment for COVID-19

Researchers test commercial assays to detect SARS-CoV-2 antibodies six months after infection

Wastewater testing can detect COVID-19 cases weeks before people show clinical signs

Case study suggests kindergartens are not SARS-CoV-2 super-spreaders

New analysis method could pave the way for important breakthroughs in immunotherapy

Favipiravir does not attenuate the progression of COVID-19

Severe cortical damage associated with COVID-19 case report

Takeda brings innovative pipeline portfolio to patients for sustained revenue growth

Study: TMEM41B transmembrane protein is a critical factor for SARS-CoV-2 replication

Interim analysis of phase 3 study shows excellent efficacy of SARS-CoV-2 vaccine

Change in mental status or falls may be misinterpreted as infection in nursing homes

Virginia Tech researchers awarded NIH grant to develop Zika virus vaccine

The impact of COVID-19 on emergency medical services: a case study

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

COVID-19 has been reported to trigger Guillain–Barré syndrome

COVID-19 may be linked to acute appendicitis in children

Researchers develop new approach for COVID-19 testing

Nearly 70% of diabetic patients in Indonesia experience disease management difficulties, study finds

Combination of venetoclax and standard therapies shows promise in high-risk myeloid blood cancers

International scientific team reports 'super-spreader' potential of Andes virus

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News